Cemex S.A.B. de C.V. Sponsored ADR vs Definium Therapeutics Inc. Common Shares — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.84B), while Definium Therapeutics Inc. Common Shares trades at $35.5 (market cap $4.71B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 2.9× Definium Therapeutics Inc. Common Shares's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| CX | DFTX | |
|---|---|---|
Market Cap | $13.84B | $4.71B |
Volume | 6,589,714 | 1,966,636 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $48.45 |
52-Week Low | $9.12 | $10.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.83B | $3.67B |
Dividend Yield | 1.3% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →